Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. […]
Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. […]
